Wim H. van Brakel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wim H. van Brakel has a total of 184 co-authors. Here are the top co-authors by number of shared publications:
- Anna Tiny Van’t Noordende
NLR, Amsterdam, The Netherlands
4 shared publications - Jan Hendrik Richardus
Affiliation Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
4 shared publications - Liesbeth Mieras
NLR, Amsterdam, The Netherlands
4 shared publications - Mitzi Waltz
Athena Institute, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands
4 shared publications - Anna Theodora Taal
NLR, Amsterdam, The Netherlands
3 shared publications Peter G Nicholls
3 shared publications
Latest Publications
- Open Access
Optimizing dosing strategies for children with leprosy: A weight-banded dosing approach
Background: Dosing guidance for children with leprosy remains operationally challenging. For children under 10 years of age, current WHO recommendations rely on mg/kg dosing of the three separate components of leprosy multidrug therapy, which are difficult to implement in routine care and may result in inconsistent drug exposures. Weight-banded dosing offers a pragmatic alternative that better aligns with pharmacokinetic principles and existing drug formulations. Methodology: A pharmacokinetic simulation study was conducted to develop harmonized weight-banded dosing regimens for rifampicin, clofazimine, and dapsone in children aged 2 to <10 years. Using the WHO dosing tool, drug exposures across harmonized weight bands were simulated and adult-equivalent systemic exposure (80-125% of adult area under the concentration-time curve) targeted. Predicted exposures were contextualized against safety reference regimens used in tuberculosis meningitis, multidrug-resistant tuberculosis, and leprosy. An iterative review process involving the WHO Technical Working Group on leprosy in children ensured clinical and operational feasibility. Results: Proposed weight-banded multidrug therapy regimens achieved adult-equivalent exposures across most weight bands. Predicted exposures modestly exceeded 125% of adult levels at the lower end of selected weight bands but remained well below safety benchmarks, namely exposures associated with daily rifampicin therapy for tuberculosis meningitis and clofazimine regimens for multidrug-resistant tuberculosis. Dapsone exposures were comparable to those achieved with current leprosy dosing. The existing 10-14-year-old child MDT blister pack could be used without modification in children weighing 25-39.9 kg and with limited tablet or gel capsule removal in children weighing 6-24.9 kg. Conclusions: A harmonized weight-banded dosing strategy was developed that enables effective, practical dosing of leprosy multidrug therapy in children under 10 years using existing free-of-charge blister packs provided through WHO. This approach improves dosing consistency, supports programmatic implementation, and provides a rational interim solution while child-friendly formulations are being developed.
Open AccessOptimizing dosing strategies for children with leprosy: A weight-banded dosing approach
Background: Dosing guidance for children with leprosy remains operationally challenging. For children under 10 years of age, current WHO recommendations rely on mg/kg dosing of the three separate components of leprosy multidrug therapy, which are difficult to implement in routine care and may result in inconsistent drug exposures. Weight-banded dosing offers a pragmatic alternative that better aligns with pharmacokinetic principles and existing drug formulations. Methodology: A pharmacokinetic simulation study was conducted to develop harmonized weight-banded dosing regimens for rifampicin, clofazimine, and dapsone in children aged 2 to <10 years. Using the WHO dosing tool, drug exposures across harmonized weight bands were simulated and adult-equivalent systemic exposure (80-125% of adult area under the concentration-time curve) targeted. Predicted exposures were contextualized against safety reference regimens used in tuberculosis meningitis, multidrug-resistant tuberculosis, and leprosy. An iterative review process involving the WHO Technical Working Group on leprosy in children ensured clinical and operational feasibility. Results: Proposed weight-banded multidrug therapy regimens achieved adult-equivalent exposures across most weight bands. Predicted exposures modestly exceeded 125% of adult levels at the lower end of selected weight bands but remained well below safety benchmarks, namely exposures associated with daily rifampicin therapy for tuberculosis meningitis and clofazimine regimens for multidrug-resistant tuberculosis. Dapsone exposures were comparable to those achieved with current leprosy dosing. The existing 10-14-year-old child MDT blister pack could be used without modification in children weighing 25-39.9 kg and with limited tablet or gel capsule removal in children weighing 6-24.9 kg. Conclusions: A harmonized weight-banded dosing strategy was developed that enables effective, practical dosing of leprosy multidrug therapy in children under 10 years using existing free-of-charge blister packs provided through WHO. This approach improves dosing consistency, supports programmatic implementation, and provides a rational interim solution while child-friendly formulations are being developed.
- Open Access
Gaps in leprosy knowledge and hidden stigma in northwest Bangladesh: A community-based mixed-method survey among patients, contacts, communities and health workers
Leprosy control requires early diagnosis, effective treatment and reduced stigma, yet community knowledge, attitudes and practices (KAP) in endemic settings remain poorly described. We assessed baseline leprosy-related KAP among key stakeholder groups in northwest Bangladesh. A community-based cross-sectional mixed-methods study was conducted in Nilphamari and Rangpur districts. We surveyed 900 respondents—index patients, close contacts, community members and health care workers—using a KAP questionnaire (score 0–9; adequate knowledge ≥7) and analyzed determinants with multivariable bootstrapped linear regression. Semi-structured interviews and focus group discussions explored explanatory models. Awareness of curability, multidrug therapy and non-contagiousness while on treatment exceeded 90% across groups, and most participants knew that disability can be prevented. Adequate knowledge was highest among health workers (89%), followed by persons affected (69%), contacts (67%) and community members (56%). Misconceptions about cause (heredity, unclean environment, supernatural or moral explanations) and transmission (skin contact, shared food) remained frequent. Higher education and being married consistently predicted better KAP, whereas older age and grade 2 disability were associated with poorer scores among index patients. Qualitative findings showed coexistence of biomedical and religious or moral explanations and highlighted internalized stigma; 42.5% of patients preferred to conceal their diagnosis despite reports of overt discrimination. In these high-endemic districts, core messages on curability and treatment have been absorbed, but knowledge gaps and hidden stigma persist among community members and vulnerable patient subgroups. Tailored, literacy-sensitive education and psychosocial support are needed to improve early detection, support post-exposure prophylaxis and reduce stigma.
Open AccessGaps in leprosy knowledge and hidden stigma in northwest Bangladesh: A community-based mixed-method survey among patients, contacts, communities and health workers
Leprosy control requires early diagnosis, effective treatment and reduced stigma, yet community knowledge, attitudes and practices (KAP) in endemic settings remain poorly described. We assessed baseline leprosy-related KAP among key stakeholder groups in northwest Bangladesh. A community-based cross-sectional mixed-methods study was conducted in Nilphamari and Rangpur districts. We surveyed 900 respondents—index patients, close contacts, community members and health care workers—using a KAP questionnaire (score 0–9; adequate knowledge ≥7) and analyzed determinants with multivariable bootstrapped linear regression. Semi-structured interviews and focus group discussions explored explanatory models. Awareness of curability, multidrug therapy and non-contagiousness while on treatment exceeded 90% across groups, and most participants knew that disability can be prevented. Adequate knowledge was highest among health workers (89%), followed by persons affected (69%), contacts (67%) and community members (56%). Misconceptions about cause (heredity, unclean environment, supernatural or moral explanations) and transmission (skin contact, shared food) remained frequent. Higher education and being married consistently predicted better KAP, whereas older age and grade 2 disability were associated with poorer scores among index patients. Qualitative findings showed coexistence of biomedical and religious or moral explanations and highlighted internalized stigma; 42.5% of patients preferred to conceal their diagnosis despite reports of overt discrimination. In these high-endemic districts, core messages on curability and treatment have been absorbed, but knowledge gaps and hidden stigma persist among community members and vulnerable patient subgroups. Tailored, literacy-sensitive education and psychosocial support are needed to improve early detection, support post-exposure prophylaxis and reduce stigma.
- Open Access
- 30 October 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (10) , e0327741
Evaluating effectiveness of self-help groups in reduction of stigma in patients with neglected tropical diseases in Southern Nigeria: A cluster randomised study
Introduction: Neglected tropical diseases (NTDs), notably leprosy and Buruli ulcer (BU), often lead to visible impairments and disabilities. Consequently, individuals affected by these conditions face stigmatization, discrimination, and mental health disorders. Stigma is particularly prevalent in leprosy, affecting self-esteem, social participation, self-efficacy, and overall quality of life. Various interventions have been developed to mitigate leprosy-related stigma, including individual and group counseling, peer support, economic empowerment initiatives, and establishment of self-help groups. However, rigorous evaluation of the various interventions through randomized controlled trials is lacking, especially within the Nigerian context, and none has included persons affected by BU. To address this gap, effectiveness of combined leprosy and BU self-help groups (SHGs) on stigma reduction was assessed as part of a larger randomized controlled study. Methodology/principal findings: A cluster randomized study was conducted in Southern Nigeria from 2021 to 2023. Five local government areas (LGAs) were selected for each of the intervention and control arms. People affected by leprosy or BU were organized into SHGs in the intervention LGAs. Control LGAs were maintained on the existing standard of care, which did not include SHGs. Monthly peer-support meetings were held for 24 months following standardized guidelines after appropriate training of SHG members. The intervention targeted perceived and experienced stigma. Pre- and post-intervention stigma assessments were conducted using the stigma assessment and reduction of impact (SARI) scale in both intervention and control LGAs. A total of 635 persons affected by leprosy or BU were recruited—362 in the intervention group and 273 in the control group. At baseline, respondents in the intervention group had a significantly higher adjusted mean total score on the SARI Stigma Scale compared to the control group, with an adjusted mean difference of 10.75 (95% CI: 8.05–13.46, p < 0.000). However, post-intervention, the adjusted mean SARI Stigma Score significantly decreased in the intervention group compared to the control group, with an adjusted mean difference of 37.72 (95% CI: 36.01–39.43, p < 0.000). Conclusion/significance: Peer-support and psychosocial support through SHGs significantly contributed to stigma reduction among persons affected by Leprosy/BU. SHGs can play a key role in stigma reduction interventions within NTD programs, contributing to the global leprosy target of achieving zero stigma and discrimination. Trial Registration: ISRCTN Registry: ISRCTN 83649248. https://trialsearch.who.int/Trial2.aspx? TrialID = ISRCTN83649248.
- 30 October 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (10) , e0327741
Open AccessEvaluating effectiveness of self-help groups in reduction of stigma in patients with neglected tropical diseases in Southern Nigeria: A cluster randomised study
Introduction: Neglected tropical diseases (NTDs), notably leprosy and Buruli ulcer (BU), often lead to visible impairments and disabilities. Consequently, individuals affected by these conditions face stigmatization, discrimination, and mental health disorders. Stigma is particularly prevalent in leprosy, affecting self-esteem, social participation, self-efficacy, and overall quality of life. Various interventions have been developed to mitigate leprosy-related stigma, including individual and group counseling, peer support, economic empowerment initiatives, and establishment of self-help groups. However, rigorous evaluation of the various interventions through randomized controlled trials is lacking, especially within the Nigerian context, and none has included persons affected by BU. To address this gap, effectiveness of combined leprosy and BU self-help groups (SHGs) on stigma reduction was assessed as part of a larger randomized controlled study. Methodology/principal findings: A cluster randomized study was conducted in Southern Nigeria from 2021 to 2023. Five local government areas (LGAs) were selected for each of the intervention and control arms. People affected by leprosy or BU were organized into SHGs in the intervention LGAs. Control LGAs were maintained on the existing standard of care, which did not include SHGs. Monthly peer-support meetings were held for 24 months following standardized guidelines after appropriate training of SHG members. The intervention targeted perceived and experienced stigma. Pre- and post-intervention stigma assessments were conducted using the stigma assessment and reduction of impact (SARI) scale in both intervention and control LGAs. A total of 635 persons affected by leprosy or BU were recruited—362 in the intervention group and 273 in the control group. At baseline, respondents in the intervention group had a significantly higher adjusted mean total score on the SARI Stigma Scale compared to the control group, with an adjusted mean difference of 10.75 (95% CI: 8.05–13.46, p < 0.000). However, post-intervention, the adjusted mean SARI Stigma Score significantly decreased in the intervention group compared to the control group, with an adjusted mean difference of 37.72 (95% CI: 36.01–39.43, p < 0.000). Conclusion/significance: Peer-support and psychosocial support through SHGs significantly contributed to stigma reduction among persons affected by Leprosy/BU. SHGs can play a key role in stigma reduction interventions within NTD programs, contributing to the global leprosy target of achieving zero stigma and discrimination. Trial Registration: ISRCTN Registry: ISRCTN 83649248. https://trialsearch.who.int/Trial2.aspx? TrialID = ISRCTN83649248.
- Open Access
- 27 November 2024
- Published by Public Library of Science (PLoS) in PLOS Mental Health
- Vol. 1 (6) , e0000191
Cross-cultural adaptation of the 5-Question Stigma Indicators in trachoma-affected communities, Ethiopia
Stigma is common in people affected with Neglected Tropical Diseases (NTDs). However, no validated tools are available to assess and monitor stigma in trachoma-affected communities. We tested the cross-cultural equivalence of the 5-question stigma indicator-affected persons (5-QSI-AP) scale in persons with trachomatous trichiasis (TT), the blinding stage of trachoma, and the 5-question stigma indicator-community stigma (5-QSI-CS) scale in person without TT, in Amhara region, Ethiopia. Conceptual, item, semantic, and operational equivalence were assessed through exploratory qualitative methods; measurement equivalence was assessed quantitatively through internal consistency, construct validity, and reproducibility. A total of 390 people participated: 181 were persons with TT, 182 persons without TT, 19 mental health, trachoma, social science, and linguistics experts, and eight interviewers. Items included in both scales were adequately relevant and important to explore stigma in the target culture. Concern about others knowing that they have TT, shame, avoidance by others, and problems getting married or in their marriage were among the issues persons with TT faced in this study community. The 5-QSI-AP had a Cronbach’s α of 0.57 for internal consistency and showed adequate discriminant validity where persons with central corneal opacity from TT had higher mean stigma scores than their counterparts. The 5-QSI-CS had a Cronbach’s α of 0.70 for internal consistency and a correlation of r = 0.23 with the Social Distance Scale (SDS) for convergent validity. The test-retest reliability analysis between the initial and repeat measures produced an intraclass correlation coefficient of 0.60 and 0.53 for the 5-QSI-AP and 5-QSI-CS respectively, and no evidence of systematic bias in mean stigma scores. The 5-QSI scales have satisfactory cultural validity to assess and monitor stigma in this trachoma-affected Amharic-speaking study population. With further cross-cultural validation, these brief and easy to administer scales would offer the possibility to rapidly measure and monitor stigma associated with NTDs.
- 27 November 2024
- Published by Public Library of Science (PLoS) in PLOS Mental Health
- Vol. 1 (6) , e0000191
Open AccessCross-cultural adaptation of the 5-Question Stigma Indicators in trachoma-affected communities, Ethiopia
Stigma is common in people affected with Neglected Tropical Diseases (NTDs). However, no validated tools are available to assess and monitor stigma in trachoma-affected communities. We tested the cross-cultural equivalence of the 5-question stigma indicator-affected persons (5-QSI-AP) scale in persons with trachomatous trichiasis (TT), the blinding stage of trachoma, and the 5-question stigma indicator-community stigma (5-QSI-CS) scale in person without TT, in Amhara region, Ethiopia. Conceptual, item, semantic, and operational equivalence were assessed through exploratory qualitative methods; measurement equivalence was assessed quantitatively through internal consistency, construct validity, and reproducibility. A total of 390 people participated: 181 were persons with TT, 182 persons without TT, 19 mental health, trachoma, social science, and linguistics experts, and eight interviewers. Items included in both scales were adequately relevant and important to explore stigma in the target culture. Concern about others knowing that they have TT, shame, avoidance by others, and problems getting married or in their marriage were among the issues persons with TT faced in this study community. The 5-QSI-AP had a Cronbach’s α of 0.57 for internal consistency and showed adequate discriminant validity where persons with central corneal opacity from TT had higher mean stigma scores than their counterparts. The 5-QSI-CS had a Cronbach’s α of 0.70 for internal consistency and a correlation of r = 0.23 with the Social Distance Scale (SDS) for convergent validity. The test-retest reliability analysis between the initial and repeat measures produced an intraclass correlation coefficient of 0.60 and 0.53 for the 5-QSI-AP and 5-QSI-CS respectively, and no evidence of systematic bias in mean stigma scores. The 5-QSI scales have satisfactory cultural validity to assess and monitor stigma in this trachoma-affected Amharic-speaking study population. With further cross-cultural validation, these brief and easy to administer scales would offer the possibility to rapidly measure and monitor stigma associated with NTDs.
- Open Access
- 1 March 2022
- Published by Lepra in Leprosy Review
- Vol. 93 (1) , 12-25
Factors influencing the mental wellbeing of persons affected by leprosy in Far-Western Nepal
Objective To investigate factors that influence the mental wellbeing of persons affected by leprosy in Far-Western Nepal. Methods The study used a cross-sectional design with a qualitative approach. Semi-structured, in-depth interviews and focus group discussions covering topics such as feelings towards and experiences with leprosy, mental wellbeing, knowledge about leprosy, social life, community, culture and future outlook were employed. The data were analysed using Framework Analysis and Thematic Open Analysis. Results A total of 25 persons affected by leprosy were included in the in-depth interviews and 13 persons participated in focus group discussions. We found that participants often experienced stigma and/or mental distress. Participants reported physical weakness or pain, activity limitations, worries about their disease and its implications, feelings of shame, suicidal thoughts, and perceived and/or internalised stigma. Factors influencing mental wellbeing included discrimination, social support, religion, participation (restrictions), (in)ability to work, community attitudes, knowledge of leprosy and cultural beliefs about the disease. Conclusions This study revealed that the majority of participants faced leprosy-related stigma, physical discomfort, restrictions in social participation and mental distress. We recommend the development of interventions such as counselling after diagnosis with leprosy, increasing leprosy awareness and knowledge, addressing negative attitudes and beliefs in the community and stimulating social participation.
- 1 March 2022
- Published by Lepra in Leprosy Review
- Vol. 93 (1) , 12-25
Open AccessFactors influencing the mental wellbeing of persons affected by leprosy in Far-Western Nepal
Objective To investigate factors that influence the mental wellbeing of persons affected by leprosy in Far-Western Nepal. Methods The study used a cross-sectional design with a qualitative approach. Semi-structured, in-depth interviews and focus group discussions covering topics such as feelings towards and experiences with leprosy, mental wellbeing, knowledge about leprosy, social life, community, culture and future outlook were employed. The data were analysed using Framework Analysis and Thematic Open Analysis. Results A total of 25 persons affected by leprosy were included in the in-depth interviews and 13 persons participated in focus group discussions. We found that participants often experienced stigma and/or mental distress. Participants reported physical weakness or pain, activity limitations, worries about their disease and its implications, feelings of shame, suicidal thoughts, and perceived and/or internalised stigma. Factors influencing mental wellbeing included discrimination, social support, religion, participation (restrictions), (in)ability to work, community attitudes, knowledge of leprosy and cultural beliefs about the disease. Conclusions This study revealed that the majority of participants faced leprosy-related stigma, physical discomfort, restrictions in social participation and mental distress. We recommend the development of interventions such as counselling after diagnosis with leprosy, increasing leprosy awareness and knowledge, addressing negative attitudes and beliefs in the community and stimulating social participation.
- Open Access
- 27 August 2021
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 15 (8) , e0009667
Detection of anti-M. leprae antibodies in children in leprosy-endemic areas: A systematic review
Background: Leprosy elimination primarily targets transmission of Mycobacterium leprae which is not restricted to patients’ households. As interruption of transmission is imminent in many countries, a test to detect infected asymptomatic individuals who can perpetuate transmission is required. Antibodies directed against M. leprae antigens are indicative of M. leprae infection but cannot discriminate between active and past infection. Seroprevalence in young children, however, reflects recent M. leprae infection and may thus be used to monitor transmission in an area. Therefore, this literature review aimed to evaluate what has been reported on serological tests measuring anti-M. leprae antibodies in children without leprosy below the age of 15 in leprosy-endemic areas. Methods and findings: A literature search was performed in the databases Pubmed, Infolep, Web of Science and The Virtual Health Library. From the 724 articles identified through the search criteria, 28 full-text articles fulfilled all inclusion criteria. Two additional papers were identified through snowballing, resulting in a total of 30 articles reporting data from ten countries. All serological tests measured antibodies against phenolic glycolipid-I or synthetic derivatives thereof, either quantitatively (ELISA or UCP-LFA) or qualitatively (ML-flow or NDO-LID rapid test). The median seroprevalence in children in endemic areas was 14.9% and was stable over time if disease incidence remained unchanged. Importantly, seroprevalence decreased with age, indicating that children are a suitable group for sensitive assessment of recent M. leprae infection. However, direct comparison between areas, solely based on the data reported in these studies, was impeded by the use of different tests and variable cut-off levels. Conclusions: Quantitative anti-PGL-I serology in young children holds promise as a screening test to assess M. leprae infection and may be applied as a proxy for transmission and thereby as a means to monitor the effect of (prophylactic) interventions on the route to leprosy elimination.
- 27 August 2021
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 15 (8) , e0009667
Open AccessDetection of anti-M. leprae antibodies in children in leprosy-endemic areas: A systematic review
Background: Leprosy elimination primarily targets transmission of Mycobacterium leprae which is not restricted to patients’ households. As interruption of transmission is imminent in many countries, a test to detect infected asymptomatic individuals who can perpetuate transmission is required. Antibodies directed against M. leprae antigens are indicative of M. leprae infection but cannot discriminate between active and past infection. Seroprevalence in young children, however, reflects recent M. leprae infection and may thus be used to monitor transmission in an area. Therefore, this literature review aimed to evaluate what has been reported on serological tests measuring anti-M. leprae antibodies in children without leprosy below the age of 15 in leprosy-endemic areas. Methods and findings: A literature search was performed in the databases Pubmed, Infolep, Web of Science and The Virtual Health Library. From the 724 articles identified through the search criteria, 28 full-text articles fulfilled all inclusion criteria. Two additional papers were identified through snowballing, resulting in a total of 30 articles reporting data from ten countries. All serological tests measured antibodies against phenolic glycolipid-I or synthetic derivatives thereof, either quantitatively (ELISA or UCP-LFA) or qualitatively (ML-flow or NDO-LID rapid test). The median seroprevalence in children in endemic areas was 14.9% and was stable over time if disease incidence remained unchanged. Importantly, seroprevalence decreased with age, indicating that children are a suitable group for sensitive assessment of recent M. leprae infection. However, direct comparison between areas, solely based on the data reported in these studies, was impeded by the use of different tests and variable cut-off levels. Conclusions: Quantitative anti-PGL-I serology in young children holds promise as a screening test to assess M. leprae infection and may be applied as a proxy for transmission and thereby as a means to monitor the effect of (prophylactic) interventions on the route to leprosy elimination.
- Open Access
- 18 June 2021
- Published by Cambridge University Press (CUP) in Cambridge Prisms: Global Mental Health
- Vol. 8
Psychosocial burden of neglected tropical diseases in eastern Colombia: an explorative qualitative study in persons affected by leprosy, cutaneous leishmaniasis and Chagas disease
Background: Leprosy, cutaneous leishmaniasis (CL) and Chagas disease (CD) are neglected tropical diseases (NTDs) with a high psychosocial burden in Norte de Santander and Arauca in Colombia. This study provides insights into affected persons' feelings, perceptions and experiences to better understand the nature of this burden. Methods: In 2018, 34 leprosy, CD and CL patients participated in four focus groups discussing the influence of the disease on mental well-being, social participation and stigma. Additionally, 13 leprosy patients participated in semi-structured interviews to further explore the health-related stigma related to this disease. Audio recordings were transcribed verbatim, and open coding was used to identify the most relevant categories and themes. Results: Persons suffering from CD reported that their mental distress was mainly caused by impairments and stress related to the progressive and incurable nature of the disease. Persons affected by CL perceived the treatment for the disease as having the most impact on their psychosocial well-being. Persons affected by leprosy reported suffering most from anticipated and experienced stigma. Conclusions: The findings indicate that these diseases are likely to impose a significant psychosocial burden on patients in the studied regions, even though these vary per condition. Consistent data collection on the psychosocial burden and the sharing of knowledge of effective interventions can contribute to the holistic approach needed to win the fight against NTDs.
- 18 June 2021
- Published by Cambridge University Press (CUP) in Cambridge Prisms: Global Mental Health
- Vol. 8
Open AccessPsychosocial burden of neglected tropical diseases in eastern Colombia: an explorative qualitative study in persons affected by leprosy, cutaneous leishmaniasis and Chagas disease
Background: Leprosy, cutaneous leishmaniasis (CL) and Chagas disease (CD) are neglected tropical diseases (NTDs) with a high psychosocial burden in Norte de Santander and Arauca in Colombia. This study provides insights into affected persons' feelings, perceptions and experiences to better understand the nature of this burden. Methods: In 2018, 34 leprosy, CD and CL patients participated in four focus groups discussing the influence of the disease on mental well-being, social participation and stigma. Additionally, 13 leprosy patients participated in semi-structured interviews to further explore the health-related stigma related to this disease. Audio recordings were transcribed verbatim, and open coding was used to identify the most relevant categories and themes. Results: Persons suffering from CD reported that their mental distress was mainly caused by impairments and stress related to the progressive and incurable nature of the disease. Persons affected by CL perceived the treatment for the disease as having the most impact on their psychosocial well-being. Persons affected by leprosy reported suffering most from anticipated and experienced stigma. Conclusions: The findings indicate that these diseases are likely to impose a significant psychosocial burden on patients in the studied regions, even though these vary per condition. Consistent data collection on the psychosocial burden and the sharing of knowledge of effective interventions can contribute to the holistic approach needed to win the fight against NTDs.
- Open Access
- 31 March 2021
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 15 (3) , e0009279
The long-term impact of the Leprosy Post-Exposure Prophylaxis (LPEP) program on leprosy incidence: A modelling study
Background: The Leprosy Post-Exposure Prophylaxis (LPEP) program explored the feasibility and impact of contact tracing and the provision of single dose rifampicin (SDR) to eligible contacts of newly diagnosed leprosy patients in Brazil, India, Indonesia, Myanmar, Nepal, Sri Lanka and Tanzania. As the impact of the programme is difficult to establish in the short term, we apply mathematical modelling to predict its long-term impact on the leprosy incidence. Methodology: The individual-based model SIMCOLEP was calibrated and validated to the historic leprosy incidence data in the study areas. For each area, we assessed two scenarios: 1) continuation of existing routine activities as in 2014; and 2) routine activities combined with LPEP starting in 2015. The number of contacts per index patient screened varied from 1 to 36 between areas. Projections were made until 2040. Principal findings: In all areas, the LPEP program increased the number of detected cases in the first year(s) of the programme as compared to the routine programme, followed by a faster reduction afterwards with increasing benefit over time. LPEP could accelerate the reduction of the leprosy incidence by up to six years as compared to the routine programme. The impact of LPEP varied by area due to differences in the number of contacts per index patient included and differences in leprosy epidemiology and routine control programme. Conclusions: The LPEP program contributes significantly to the reduction of the leprosy incidence and could potentially accelerate the interruption of transmission. It would be advisable to include contact tracing/screening and SDR in routine leprosy programmes.
- 31 March 2021
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 15 (3) , e0009279
Open AccessThe long-term impact of the Leprosy Post-Exposure Prophylaxis (LPEP) program on leprosy incidence: A modelling study
Background: The Leprosy Post-Exposure Prophylaxis (LPEP) program explored the feasibility and impact of contact tracing and the provision of single dose rifampicin (SDR) to eligible contacts of newly diagnosed leprosy patients in Brazil, India, Indonesia, Myanmar, Nepal, Sri Lanka and Tanzania. As the impact of the programme is difficult to establish in the short term, we apply mathematical modelling to predict its long-term impact on the leprosy incidence. Methodology: The individual-based model SIMCOLEP was calibrated and validated to the historic leprosy incidence data in the study areas. For each area, we assessed two scenarios: 1) continuation of existing routine activities as in 2014; and 2) routine activities combined with LPEP starting in 2015. The number of contacts per index patient screened varied from 1 to 36 between areas. Projections were made until 2040. Principal findings: In all areas, the LPEP program increased the number of detected cases in the first year(s) of the programme as compared to the routine programme, followed by a faster reduction afterwards with increasing benefit over time. LPEP could accelerate the reduction of the leprosy incidence by up to six years as compared to the routine programme. The impact of LPEP varied by area due to differences in the number of contacts per index patient included and differences in leprosy epidemiology and routine control programme. Conclusions: The LPEP program contributes significantly to the reduction of the leprosy incidence and could potentially accelerate the interruption of transmission. It would be advisable to include contact tracing/screening and SDR in routine leprosy programmes.
- 1 March 2021
- Published by Lepra in Leprosy Review
- Vol. 92 (1) , 59-74
Mental wellbeing among people affected by leprosy in the Terai region, Nepal
- 1 March 2021
- Published by Lepra in Leprosy Review
- Vol. 92 (1) , 59-74
Mental wellbeing among people affected by leprosy in the Terai region, Nepal
- Open Access
- 25 February 2021
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 15 (2) , e0009146
Number of people requiring post-exposure prophylaxis to end leprosy: A modeling study
Background: Worldwide, around 210,000 new cases of leprosy are detected annually. To end leprosy, i.e. zero new leprosy cases, preventive interventions such as contact tracing and post-exposure prophylaxis (PEP) are required. This study aims to estimate the number of people requiring PEP to reduce leprosy new case detection (NCD) at national and global level by 50% and 90%. Methodology/Principal findings: The individual-based model SIMCOLEP was fitted to seven leprosy settings defined by NCD and MB proportion. Using data of all 110 countries with known leprosy patients in 2016, we assigned each country to one of these settings. We predicted the impact of administering PEP to about 25 contacts of leprosy patients on the annual NCD for 25 years and estimated the number of contacts requiring PEP per country for each year. The NCD trends show an increase in NCD in the first year (i.e. backlog cases) followed by a significant decrease thereafter. A reduction of 50% and 90% of new cases would be achieved in most countries in 5 and 22 years if 20.6 and 40.2 million people are treated with PEP over that period, respectively. For India, Brazil, and Indonesia together, a total of 32.9 million people requiring PEP to achieve a 90% reduction in 22 years. Conclusion/Significance: The leprosy problem is far greater than the 210,000 new cases reported annually. Our model estimates of the number of people requiring PEP to achieve significant reduction of new leprosy cases can be used by policymakers and program managers to develop long-term strategies to end leprosy.
- 25 February 2021
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 15 (2) , e0009146
Open AccessNumber of people requiring post-exposure prophylaxis to end leprosy: A modeling study
Background: Worldwide, around 210,000 new cases of leprosy are detected annually. To end leprosy, i.e. zero new leprosy cases, preventive interventions such as contact tracing and post-exposure prophylaxis (PEP) are required. This study aims to estimate the number of people requiring PEP to reduce leprosy new case detection (NCD) at national and global level by 50% and 90%. Methodology/Principal findings: The individual-based model SIMCOLEP was fitted to seven leprosy settings defined by NCD and MB proportion. Using data of all 110 countries with known leprosy patients in 2016, we assigned each country to one of these settings. We predicted the impact of administering PEP to about 25 contacts of leprosy patients on the annual NCD for 25 years and estimated the number of contacts requiring PEP per country for each year. The NCD trends show an increase in NCD in the first year (i.e. backlog cases) followed by a significant decrease thereafter. A reduction of 50% and 90% of new cases would be achieved in most countries in 5 and 22 years if 20.6 and 40.2 million people are treated with PEP over that period, respectively. For India, Brazil, and Indonesia together, a total of 32.9 million people requiring PEP to achieve a 90% reduction in 22 years. Conclusion/Significance: The leprosy problem is far greater than the 210,000 new cases reported annually. Our model estimates of the number of people requiring PEP to achieve significant reduction of new leprosy cases can be used by policymakers and program managers to develop long-term strategies to end leprosy.